Patient Monitoring Devices Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$5,000$10,000

Patient Monitoring Devices Market is expected to project a notable CAGR of 6.2% in 2030.

Clear

Description

Patient Monitoring Devices Market: Market Segments: By Type (Hemodynamic Monitoring, Neuromonitoring, Cardiac Monitoring, Fetal & Neonatal Monitoring, Respiratory Monitoring, Multi-Parameter Monitoring, Remote Patient Monitoring, Weigh Monitoring, And Temperature Monitoring Devices); By End User (Hospitals & Clinics, Home Settings, and Ambulatory Surgical Centers); and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030

Product Overview
Patient monitoring devices are a technology used to collect and electronically transmit medical and health-related data from individuals at one location to a healthcare provider at another location. Patient monitoring equipment continuously tracks patient’s vital health signs, such as respiratory rate, heart rate, and rhythm, blood pressure, saturation of blood oxygen, and many other parameters.

Market Highlights
Patient Monitoring Devices Market is expected to project a notable CAGR of 6.2% in 2030.
Patient Monitoring Devices Market to surpass USD 60.3 Billion by 2030 from USD 20.2 billion in 2018 in terms of value growing at a CAGR of 6.2% throughout the forecast period, i.e., 2019-30. A key trend in patient care is the integration of monitoring technologies into smartphones and wireless devices, leading to the introduction of remote monitoring systems, mobile cardiac telemetry devices, mobile personal digital assistant (PDA) systems, outpatient wireless EEG recorders and outpatient event monitors, which are key factors that support market growth.

Patient Monitoring Devices Market: Segments
Cardiac Monitoring Devices Segment to grow with the highest CAGR of XX.X% during 2019-30
Patient Monitoring Devices Market is segmented by type as hemodynamic monitoring, neuromonitoring, cardiac monitoring, fetal & neonatal monitoring, respiratory monitoring, multi-parameter monitoring, remote patient monitoring, weigh monitoring, and temperature monitoring devices. The cardiac monitoring devices segment is estimated to lead the market with a share of over 26.0% of in Patience monitoring device market in 2018 and this trend is expected to continue during the forecast period. This is attributed to an increase in the prevalence of different cardiovascular diseases throughout the world each year, such as congestive heart failure and stroke.

Patient Monitoring Devices Market: Market Dynamics
Drivers
Rising Burden of Chronic Diseases
Chronic heart disease, diabetes, and chronic respiratory diseases are the world’s leading causes of mortality and morbidity. 75% of healthcare costs are accounted for by chronic care management. The rise in the prevalence of chronic circumstances places a huge financial burden on caregivers. It thus decreases readmissions and prevents hospitalizations that are avoidable.
Restrain
Risk associated with invasive monitoring devices
Several risks are associated with the use of invasive monitoring systems, such as discomfort associated with the insertion of monitoring tools, such as pulmonary artery catheters (PAC). Some other major risks are air embolism, sepsis, bleeding / hematoma formation, cardiac arrhythmias, decreased distal limb circulation, haemorrhage, damage to the nerves (during insertion), thrombosis, air embolism, and pulmonary capillary necrosis. The mortality rate during invasive procedures is increased by these factors. Consequently, the risks mentioned above limit the use of invasive monitoring devices.

Patient Monitoring Devices Market: Regions
Patient Monitoring Devices Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC and MENA.
Patient Monitoring Devices Market in North America led the market in 2018. The key factors supporting market growth in North America are increasing R&D to develop novel sensor-based patient monitoring systems, increasing infectious disease prevalence, safety concerns, and technological advances in patient monitoring device products. In addition, most of the world’s leading companies are headquartered in the region or have a strong presence in that market, another key factor that is attributed to the market’s significant growth. Europe, particularly Western European countries, is expected to remain the second most profitable region over the forecast period due to a higher mortality rate and rising demand for low-cost treatment. High-impact drivers for regional growth are increasing demand for in-house monitoring, supportive central data management systems and increasing the accuracy and efficiency of remote patient monitoring systems.

Patient Monitoring Devices Market: Key Players
• Abbott Laboratories
o Company Overview
o Business Strategy
o Key Product Offerings
o Financial Performance
o Key Performance Indicators
o Risk Analysis
o Recent Development
o Regional Presence
o SWOT Analysis
• Aerotel Medical Systems
• AMD Global Telemedicine
• Baxter International Inc.
• Boston Scientific Corporation
• GE Healthcare
• Masimo Corporation
• Medtronic PLC
• Omron Corporation

Patient Monitoring Devices Market report also contains analysis on:
Patient Monitoring Devices Market Segments:
By Product:
Hemodynamic Monitoring Devices
o Blood Glucose
o Cholesterol
o Blood Gas & Electrolyte Analyzers/Monitors
o Blood Pressure
• Neuromonitoring Devices
o Electroencephalograph (EEG) Devices
o Transcranial Dopplers (TCD)
o Magnetoencephalography (MEG) Devices
o Intracranial Pressure Monitors (ICP)
o Cerebral Oximeters
• Cardiac Monitoring Devices
o Electrocardiogram (ECG) Devices
o Holter Monitor
o Event Monitors
o Others
• Fetal & Neonatal Monitoring Devices
o Ultrasound
o Electronic Fetal Monitoring Devices
o Fetal Doppler Monitoring Devices
o Other Fetal & Neonatal Monitoring Devices
• Respiratory Monitoring Devices
o Capnographs
o Spirometers
o Sleep Apnea Monitor
o Pulse Oximeters
• Multiparameter Monitoring Devices
o High Acuity
o Mid Acuity
o Low Acuity
Remote Patient Monitoring Devices
• Weight Monitoring Devices
• Temperature Monitoring Devices
By End User:
• Hospitals
• Ambulatory Surgery Centers
• Home Care Settings
• Other
• Patient Monitoring Devices Market Dynamics
• Patient Monitoring Devices Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

 

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

Contents
1. Executive Summary
2. Patient Monitoring Devices Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Patient Monitoring Devices Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Patient Monitoring Devices Market
11.1. Market Size & forecast, 2019A-2030F
11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12. Remote Patient Monitoring (RPM): Market Segmentation
12.1. By Regions
12.1.1. North America:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Europe:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. Asia-Pacific:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.4. MEA:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.5. Latin America:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By Type: Market Share (2020-2030F)
12.2.1. Hemodynamic Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Neuromonitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.3. Cardiac Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.4. Fetal & Neonatal Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.5. Respiratory Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.6. Multiparameter Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.7. Remote Patient Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.8. Weight Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.9. Temperature Monitoring Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3. By End User: Market Share (2020-2030F)
12.3.1. Hospitals, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.2. Ambulatory Surgery Centers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.3. Home Care Settings, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.4. Other, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
13. Company Profile
13.1.1. Abbott Laboratories
13.1.2. Company Overview
13.1.3. Company Total Revenue (Financials)
13.1.4. Market Potential
13.1.5. Global Presence
13.1.6. Key Performance Indicators
13.1.7. SWOT Analysis
13.1.8. Product Launch
13.2. Aerotel Medical Systems
13.3. AMD Global Telemedicine
13.4. Baxter International Inc.
13.5. Boston Scientific Corporation
13.6. GE Healthcare
13.7. Masimo Corporation
13.8. Medtronic PLC
13.9. Omron Corporation

14 Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.